RAC 1.82% $1.68 race oncology ltd

I think you must have completely misunderstood my questions, so...

  1. 352 Posts.
    lightbulb Created with Sketch. 799
    I think you must have completely misunderstood my questions, so I'll try to re-phrase them. You may be able to answer the first but I would assume you do not know the answers to the second two, unless it's been discussed somewhere else and I've missed it.
    1) Do FTO/METTL3/m6A levels etc. in animals behave similarly, and have similar effects (e.g. re-sensitizing resistant cancer cells as you mention), to the way the do in humans?
    2) If so, has Race measured the effect that Bisantrene has on m6A levels in any of the animal studies that it has conducted?
    3) If animal m6A levels are relevant/similar in behaviour to humans, and Race hasn't looked at m6A levels in the animal studies, why?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.68
Change
0.030(1.82%)
Mkt cap ! $281.0M
Open High Low Value Volume
$1.65 $1.68 $1.65 $48.25K 29.16K

Buyers (Bids)

No. Vol. Price($)
1 824 $1.67
 

Sellers (Offers)

Price($) Vol. No.
$1.69 500 1
View Market Depth
Last trade - 10.18am 04/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.